PGEN vs WST · rev $78.2M vs P/E 35, rev $1.72B
Precigen Inc (PGEN) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Precigen Inc (PGEN) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported PGEN revenue for 2026-06-30 was $78.2M. Net income was $12.1M. PGEN currently screens at market cap $419.2M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
PGEN currently screens at market cap $419.2M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the PGEN and WST stock pages for the full models.
Not investment advice.